Phosphorylation of 4EBP1 (also known as eukaryotic translation initiation factor 4E-binding protein) was also modulated by treatment, although this lacked significance owing to variable phosphorylation of 4EBP1 in control tumours. This evidence concerns the gene EIF4EBP1 and neoplasm.